FDA Adverse Event Malfunction Summary report: N

VITROS IMMUNODIAGNOSTIC PRODUCT INTACT PTH REAGENT PACK

MDR report key: 6028241 · Received October 13, 2016

Report

Report Number
3007111389-2016-00188
Event Type
Malfunction
Date Received
October 13, 2016
Date of Event
September 16, 2016
Report Date
October 13, 2016
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
CEW
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION DETERMINED THAT DURING INTERNAL TESTING, HIGHER THAN EXPECTED VITROS IPTH RESULTS WERE OBTAINED FROM TWELVE PATIENT SAMPLES PROCESSED WHEN COMPARED TO A NON-VITROS METHOD (ROCHE) TO WHICH THE VITROS IPTH SHOULD HAVE A 1:1 CORRELATION. ORTHO HAS IDENTIFIED A 40% POSITIVE BIAS COMPARING VITROS IPTH TO ROCHE ACROSS ALL SAMPLES IN THE CORRELATION STUDY. THE ORIGIN OF THE POSITIVE BIAS IS CURRENTLY NOT KNOWN. THE INVESTIGATION IS ONGOING. THE FDA (B)(4) WAS NOTIFIED OF THIS ISSUE ON 13 OCTOBER 2016. REFER TO REPORT NUMBER 3007111389-10/13/2016-001-C. (B)(4).

Description of Event or Problem · 1

DURING INTERNAL TESTING, AN ORTHO CLINICAL DIAGNOSTICS (ORTHO) PRINCIPLE SCIENTIST OBTAINED HIGHER THAN EXPECTED VITROS IPTH RESULTS ON TWELVE PATIENT SAMPLES COMPARED TO A NON-VITROS METHOD (ROCHE) TO WHICH THE VITROS IPTH SHOULD HAVE A 1:1 CORRELATION. (B)(6). BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED. THE VITROS IPTH RESULTS WERE OBTAINED DURING INTERNAL TESTING AND WERE NOT REPORTED TO PHYSICIANS. THERE WERE NO ALLEGATION OF PATIENT HARM AS A RESULT OF THESE EVENTS. THIS REPORT IS NUMBER TWO OF SEVEN MDR'S FOR THIS EVENT. SEVEN 3500A FORMS ARE BEING SUBMITTED FOR THIS EVENT AS SEVEN DEVICES WERE INVOLVED. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
679132 VITROS IMMUNODIAGNOSTIC PRODUCT INTACT PTH REAGENT PACK IN VITRO DIAGNOSTIC CEW ORTHO-CLINICAL DIAGNOSTICS 0738

Patients

Seq Age Sex Outcome Treatment
1